Prolonged chronic inflammation progresses to dysplasia in a novel rat model of colitis-associated colon cancer.
Inflammatory bowel disease (IBD) is a gastrointestinal disorder of unknown etiology or cure. One complication of IBD is an increased risk for development of colon cancer. The aims of this study were to use a previously established rat model of colitis to develop a new model of colitis-associated colon cancer and ascertain the involvement of three cancer-related genes: K-ras, adenomatous polyposis coli (APC), and p53. Four groups of rats were used: reactivated 1,2-dimethylhydrazine [DMH; trinitrobenzene sulfonic acid (TNBS) was used to induce colitis followed by a weekly s.c. dose of DMH], prolonged reactivation (inflammation was induced with TNBS, then maintained twice a week), saline-DMH (animals received saline instead of TNBS followed by a weekly dose of DMH), and normal (received no treatment). Animals were sacrificed at 5, 10, or 15 weeks, and colon samples were taken for pathologic analysis and gene mutation detection. No dysplasia was found in the normal group. The highest incidences of dysplasia were as follows: prolonged reactivation group at 5 weeks (60%), reactivated DMH group at 10 weeks (83%), and saline-DMH group at 15 weeks (67%). Carcinoma was found in both the prolonged reactivation and saline-DMH groups. No mutations were found in the K-ras oncogene; however 62% of the APC samples (exon 15 at nucleotide 2778) and 76% of p53 (exon 6 at nucleotide 1327) showed substitutions. The prolonged reactivation group may be considered a new model of colitis-associated colon cancer, offering the potential to study cancer prevention strategies for patients with IBD.
Santiago
Cariluz
C
Department of Physiology and Pharmacology, Ponce School of Medicine, Ponce, Puerto Rico.
Pagán
Beatriz
B
Isidro
Angel A
AA
Appleyard
Caroline B
CB
D019813:1,2-Dimethylhydrazine / Q000494:pharmacology; D025601:Adenomatous Polyposis Coli Protein / Q000378:metabolism; D000818:Animals; D002277:Carcinoma / Q000235:genetics / Q000378:metabolism; D002908:Chronic Disease; D003092:Colitis / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology; D003110:Colonic Neoplasms / Q000235:genetics / Q000276:immunology* / Q000473:pathology*; D005091:Exons; D007249:Inflammation / Q000473:pathology*; D015212:Inflammatory Bowel Diseases / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D051381:Rats; D013997:Time Factors; D014302:Trinitrobenzenesulfonic Acid / Q000494:pharmacology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D025601:Adenomatous Polyposis Coli Protein; D016159:Tumor Suppressor Protein p53; D014302:Trinitrobenzenesulfonic Acid; D019813:1,2-Dimethylhydrazine